Evidence map›Paper›PMID 36691480›Full record

ArticlePeerJ2023

Prevalence and risk factors of COVID-19-related generalized anxiety disorder among the general public in China: a cross-sectional study.

Yi Xia, Qi Wang, Lushaobo Shi, Zengping Shi, Jinghui Chang, Richard Xu, Huazhang Miao, Dong Wang

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yi Xia *School of Health Management, Southern Medical University, Guangzhou, Guangdong, China.
Qi Wang *Shenzhen People's Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Lushaobo ShiSchool of Health Management, Southern Medical University, Guangzhou, Guangdong, China.
Zengping ShiSchool of Health Management, Southern Medical University, Guangzhou, Guangdong, China.
Jinghui ChangSchool of Health Management, Southern Medical University, Guangzhou, Guangdong, China.
Richard XuDepartment of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong, China.ORCID 0000-0002-4720-5172
Huazhang MiaoSchool of Health Management, Southern Medical University, Guangzhou, Guangdong, China.
Dong WangSchool of Health Management, Southern Medical University, Guangzhou, Guangdong, China.
Southern Medical University · CNHong Kong Polytechnic University · HKSouthern University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to estimate the prevalence of generalized anxiety disorder in China during the coronavirus disease 2019 (COVID-19) pandemic and identify its associated factors. Methods: A cross-sectional study was conducted among the general population in China from March 16 to April 2, 2020. The participants were recruited using stratified random sampling. Data on demographic characteristics and COVID-19 related factors were obtained using self-administered questionnaires. The anxiety score was measured based on the Chinese version of the Generalized Anxiety Disorder 7-item Scale (GAD-7). Results: The study comprised 10,824 participants, of which 37.69% had symptoms of anxiety. The risk factors for anxiety symptoms included poor self-reported health ( Conclusions: Self-reported health status, chronic diseases, quarantine, and perceptions of COVID-19 were significantly associated with GAD-7 scores, indicating that mental health interventions are urgently needed during pandemics, especially for high-risk groups.

Indexed as

COVID-19Anxiety DisordersChinaCross-Sectional StudiesDepressionHumansPrevalenceRisk FactorsSARS-CoV-2Anxiety disordersCOVID-19EpidemiologyPublic healthRisk management

Identifiers

PMID36691480
PMCPMC9864122
OpenAlexW4317392391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.